In the MediaHome› Company Overview› News & Events› In the MediaMay 20, 2022 Switching from CAD to AI improves performance of screening DBT Read MoreMay 20, 2022 iCAD’s 3D mammography AI catches more breast cancers in real-world study Read MoreMay 19, 2022 New Image-Based Risk Model Helps Predict Future Breast Cancers Read MoreMay 18, 2022 iCAD announces new research supporting ProFound AI for DBT Read MoreMay 16, 2022 New Research Finds iCAD’s ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models Read MoreMay 12, 2022 Digital Breast Tomosynthesis Tool Can Help Predict Breast Cancer Read MoreMarch 23, 2022 iCAD Accelerates Cancer Detection and Treatment with NVIDIA AI Enterprise Stack Read MoreDecember 2, 2021 More research, transparency needed for combining AI with DBT Read MoreDecember 1, 2021 Arterys and iCAD sign distribution deal Read MoreDecember 1, 2021 Arterys and iCAD sign global distribution agreement Read MoreNovember 30, 2021 Arterys and iCAD join forces to roll out breast health AI solutions worldwide Read MoreNovember 29, 2021 AI Enterprise Helps Researchers, Hospitals Targeting Cancer Hit the Mark Read More Previous 1 … 6 7 8 9 10 … 23 Next
